Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

PureTech (PRTC) Share Price

Price 119.40p on 11-09-2026 at 18:15:10
Change -1.20p -1%
Buy 119.80p
Sell 119.00p
Last Trade: Buy 10,405.00 at 119.40p
Day's Volume: 268,224
Last Close: 119.40p
Open: 120.60p
ISIN: GB00BY2Z0H74
Day's Range 119.40p - 122.40p
52wk Range: 104.80p - 142.80p
Market Capitalisation: £292.74m
VWAP: 119.96799p
Shares in Issue: 245.18m

PureTech (PRTC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 10,405 119.40p Automatic Execution
16:35:09 - 11-Sep-26
Buy* 6,069 119.40p Automatic Execution
16:35:09 - 11-Sep-26
Buy* 120,738 119.40p Suspected BUY Trade
16:35:09 - 11-Sep-26
Buy* 775 119.60p Automatic Execution
16:26:05 - 11-Sep-26
Buy* 775 119.60p Automatic Execution
16:26:05 - 11-Sep-26
Buy* 775 119.60p Automatic Execution
16:26:05 - 11-Sep-26
Buy* 725 119.60p Automatic Execution
16:25:44 - 11-Sep-26
Sell* 397 119.40p Automatic Execution
16:25:26 - 11-Sep-26
Sell* 1,221 119.40p Automatic Execution
16:25:25 - 11-Sep-26
Sell* 754 119.40p Automatic Execution
16:25:25 - 11-Sep-26
See more PureTech trades

PureTech (PRTC) Share Price History

Time period:
to
Date Open High Low Close Volume
11th Sep 2026 (Fri) 120.60 122.40 119.40 119.40 268,224
10th Sep 2026 (Thu) 120.00 121.80 118.40 120.60 842,178
9th Sep 2026 (Wed) 123.00 123.00 119.80 120.80 446,134
8th Sep 2026 (Tue) 118.00 121.40 118.00 121.40 538,419
7th Sep 2026 (Mon) 123.00 123.00 120.00 120.60 265,671
4th Sep 2026 (Fri) 126.00 126.00 119.80 121.60 837,625
3rd Sep 2026 (Thu) 125.00 127.00 121.00 126.00 1,591,337
2nd Sep 2026 (Wed) 125.00 125.00 119.20 120.40 345,166
1st Sep 2026 (Tue) 129.00 129.00 119.60 120.40 479,431
31st Aug 2026 (Mon) 126.00 126.00 126.00 126.00 0
28th Aug 2026 (Fri) 127.20 128.20 126.00 126.00 859,639
27th Aug 2026 (Thu) 123.40 129.20 123.40 126.00 1,560,091
26th Aug 2026 (Wed) 122.00 122.00 118.80 120.40 2,780,078
25th Aug 2026 (Tue) 119.40 121.20 118.00 121.20 1,301,751
24th Aug 2026 (Mon) 119.00 119.00 114.00 118.80 1,172,722
21st Aug 2026 (Fri) 117.60 117.60 116.00 117.60 497,909
20th Aug 2026 (Thu) 119.40 120.80 116.80 116.80 242,224
19th Aug 2026 (Wed) 116.40 120.00 114.80 119.20 319,044
18th Aug 2026 (Tue) 116.00 117.80 113.00 115.80 791,884
17th Aug 2026 (Mon) 117.80 120.40 117.00 117.60 237,503
14th Aug 2026 (Fri) 120.00 122.20 118.00 118.80 464,513
13th Aug 2026 (Thu) 122.80 125.00 122.20 122.20 571,219
See more PureTech price history

PureTech (PRTC) Regulatory News

Date Source Headline
9th Sep 2026 6:00 pm RNS-R PRTC's SPTX: New Positive Phase 1 GlyphAllo Data
4th Sep 2026 5:30 pm RNS Holding(s) in Company
4th Sep 2026 7:00 am RNS Notice of Results
1st Sep 2026 7:00 am RNS Total Voting Rights
28th Aug 2026 7:00 am RNS Holding(s) in Company
25th Aug 2026 12:05 pm RNS-R PRTC's Celea:2 Deupirfenidone Presentations at ERS
18th Aug 2026 5:30 pm RNS PDMR Notification RSU Vesting
3rd Aug 2026 7:00 am RNS Total Voting Rights
31st Jul 2026 5:00 pm RNS PDMR Notification RSU Vesting
17th Jul 2026 5:00 pm RNS PDMR Notification RSU Vesting
See more PureTech regulatory news

PureTech (PRTC) Share News

EARNINGS AND TRADING: Pebble Beach revenue grows as forecast

9th Sep 2026 19:21

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

PureTech Health announces first patient dosing in Celea phase 3 trial

13th Jul 2026 10:17

(Alliance News) - PureTech Health PLC on Monday said its founded entity Celea Therapeutics has announced the first dosing in a phase 3 trial. Read More

LONDON BRIEFING: GSK hails cancer trial success; Plus500 backs outlook

13th Jul 2026 07:59

(Alliance News) - GSK reports positive Jemperli trial data, while Plus500 posts record first-half revenue. Elsewhere, Heathrow's first-half passenger traffic edged higher despite a June decline caused by weaker Middle East travel. Read More

DIRECTOR DEALINGS: PureTech Health directors buy GBP176,000 in shares

9th Jul 2026 16:37

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News: Read More

PureTech launches Celea Therapeutics with USD180 million financing

2nd Jul 2026 15:21

(Alliance News) - PureTech Health PLC on Thursday said its founded entity Celea Therapeutics Inc has completed a USD180 million financing, which will enable the early launch of a phase 3 drug trial. Read More

See more PureTech news
FTSE 100 Latest
Value10,650.44
Change41.52

Login to your account

Forgot Password?

Not Registered